Hormonal Changes in Pregnancy*
MICHAEL E. YANNONE, M.D.
Visiting Professor of Biochemistry, Medical University of South
Carolina, Charleston, South Carolina; Professor of Obstetrics and
Gynecology, University of Iowa College of Medicine, Iowa City, Iowa

Because of the time factor involved, it would be
an impossible task to present the vast body of
biochemical information accumulated during the
last decade on the endocrine aspects of pregnancy.
However, certain key points can be made concerning
the feto-placental unit and the hormone levels and
effects in normal gestation. These concepts will be
discussed not merely for their academic value, but
also as a base to evaluate our present diagnostic
and therapeutic endeavors in obstetrical practice.
With the audience's indulgence, an occasional personal conjecture will be interjected concerning
hormonal mechanisms and clinical practices.
Feto-Placental Unit. The fetus and the placenta
are incomplete steroidogenic systems. They lack the
capability of synthesizing all necessary steroidal
hormones from more simple precursors in contrast
to the ovaries, testes, and adult adrenal cortex. To
complete the task a well-coordinated interdigitation
of the synthetic capabilities of fetus, placenta, and
mother is required. Since the mother is involved,
one wonders whether the term "feto-maternoplacental unit" would not be more appropriate.
First the fetal adrenal cortex and then the
placenta will be discussed; hopefully, emphasizing
the information which may have practical clinical
significance.
A. Adrenal Cortex. The fetal zone of the
adrenal cortex persists only during gestation, constitutes about 80% of the gland, and is active in
steroid metabolism. In the first trimester, it is
believed this zone is primarily stimulated by human
chorionic gonadotrophin (HCG); ACTH gaining
prominence in control thereafter.
The biochemical capabilities and limitations of
the fetal adrenal cortex are shown in Fig. 1. Utilizing
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acetate as a precursor, the fetal zone more readily
synthesizes the t::..5-3{3 hydroxysteroids pregnenolone and dehydroepiandrosterone (DHEA) than
the t::..4-3 ketosteroids such as cortisol and aldosterone. This is because of a relative block in 3{3hydroxy dehydrogenase and t::..5 isomerase activity.
Thus, the synthesis of large amounts of DHEA and
its sulfate is favored, and they are transported to the
placenta as such or after 16a-hydroxylation by the
fetal adrenal or liver. The placenta can metabolize
these androgens to estrogens as will be shown
shortly.
However, such a biosynthetic lack would
leave the fetus in jeopardy because of a cortisol and
aldosterone deficiency. This is rectified by the
fact that the fetal zone can utilize the readily
available placental progesterone to produce these
needed hormones. In fact, after the tenth week of
gestation, the increasing placental progesterone
secretion may enhance the 17,a, 21, and 11{3
hydroxylase capability of the fetal adrenal cortex
to produce the corticoids . Also, the ready passage of
maternal cortisol across the placenta is a secondary
protective mechanism.
B. Placenta. This endocrine organ is incapable
of synthesizing large quantities of progesterone and
estrogens from the simple precursor acetate. However, it can efficiently convert maternal plasma
cholesterol to progesterone as shown in Fig. 2. This
is clinically important for it means that an intact maternal-placental circulation will produce essentially
normal progesterone levels even though a fetal demise has occurred. The progesterone produced by the
placenta can be metabolized by the mother and fetus
to less active progestational metabolites or can be
utilized by the fetal adrenal as already described.
Since a 17 a-hydroxy lase deficiency in the placenta
precludes the conversion of progesterone to androgens and subsequently estrogens, another mechanism
must exist for placental estrogen synthesis.
43
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Fig. I-Pathways of steroid metabolism in the human fetal adrenal cortex. The major secretory products are boxed in. (Reprinted
with permission from Villee. New Eng. J. Med. 281: 473, 1969.)

As depicted in Fig. 3, the placenta produces
estrogens from androgens of maternal and fetal
adrenal origin. Androstenedione, DHEA, and testosterone are converted by the placenta to estradiol
and estrone. It is estimated that the mother and
fetus each contribute about 50 % of the androgens
which are made into these 2 estrogens. Since the
ability to 16.a-hydroxylate androgens is essentially
limited to the fetal adrenal and liver, the fetus is
the major contributor of 16a-hydroxylated androstenedione, DHEA, and testosterone which are
converted by the placenta to estriol. The maternal
contribution to estriol at term is less than 10% and
probably arises from her adrenal androgens which
escape conversion to estradiol and estrone on passage
through the placenta to fetus. In the fetus, however,
her androgens can be hydroxylated at the 16a

position before recirculation back to the placenta
where synthesis to estriol can occur.
The above information indicates that the
clinical assay in pregnancy of plasma progesterone
or its major metabolite, pregnanediol, in the urine
would mirror placental integrity. On the other hand,
estrogen assays, particularly urinary estriol, would
reflect fetal integrity.
Hormone Secretion Patterns and Effects in Normal Gestation.
A. Progesterone. The corpus luteum appears
to be the initial source of progesterone in pregnancy. Subsequently, it is produced by the placenta
in increasing amounts from maternal cholesterol.
This transition of secretion from one gland to the
other is shown in Fig. 4. Both plasma 17a-hydroxy
progesterone and progesterone of corpus luteum
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produces 200-300 mgms of progesterone daily. The
role of this large amount of hormone is not well
defined, but possible metabolic functions are:
1. The maintenance of growth and development
of the fetus; for example, it is a precursor
steroid for the synthesis of corticoids by the
fetal adrenal cortex.
2. An immunosuppressive agent to protect the
feta-placental homotransplant.
3. A defense mechanism acting on the myometrium to prevent premature expulsion of
the fetus.
4. Prepare the breasts for lactation.
5. Mediate a variety of biochemical events;
for example, antagonize at the renal tubule
the effects of the increased aldosterone concentration found in pregnancy.

20 a- o;hydropr09esleron•

Fig. 2-Principal precursors and metabolites of progesterone
in the human placenta. The m ajor steroid secreted by the
placenta (progesterone) is boxed in. (Reprinted with permission from Villee. New Eng. J. Med. 281 :473, 1969.)

origin are seen to peak at 3-4 weeks after ovulation. At 6-8 weeks post-ovulation, the progesterone reaches a nadir while the 17 a-hydroxy progesterone continues to decline. Since the placenta
lacks significant 17a:-hydroxylase capability, it is assumed that the secondary rise in progesterone reflects
placental function. It is of interest to note that
HCG-believed to maintain the corpus luteum of
pregnancy-continues to rise while both hormones
of corpus luteum origin are declining.
The secondary rise in placental progesterone
continues to increase progressively to a maximum
plateau at 36-40 weeks. This is seen from our data
in Fig. 5, where the level at 8 weeks of 2 micrograms % increases linearly to about 14 micrograms
% at term. The curve seems to parallel that of
placental weight and is of similar configuration to
that of urinary pregnanediol as depicted in Fig. 6.
It is important to note that no significant drop
in progesterone occurs prior to labor. However,
during parturition we and others have found a
slight downward trend of mean values and this may
be a reflection of placental ischemia secondary
to the uterine contractions. There is a rapid drop
in the plasma progesterone after delivery of the
placenta verifying the hormone's short half-life.
It has been estimated that the term placenta

B. The Estrogens. Quantitatively, estriol is the
major estrogen of human pregnancy. Its biologic
potency, however, is significantly less than that of
estradiol and estrone. The urinary excretion curve
for estriol is presented in Fig. 7; the amount rising
from low early levels to high levels at term. An
acceleration in the increase is apparent during the
last few weeks. There seems to be a good correlation between the estriol curve and that for the
fetal weight. Klapper, reviewing the literature, found
the average levels to be 10.1, 14.2, 19.8, and 26
mgms at 28, 32, 36, and 40 weeks respectively.
Similar curves for urinary estradiol and estrone
have been found, but the amounts are in the microgram range. These two estrogens, like estriol, probably reflect the status of the feta-placental unit.
Munson in our group has assayed unconjugated
estradiol in the plasma of normal · pregnancies. A
mean value of 200 nanograms % in early pregnancy
(9-16 weeks) rose to 1196 nanograms % during the last 8 weeks. A curve configuration similar to
urinary estrogen excretion patterns was obtained.
I suspect that the estrogenic effects of pregnancy are primarily due to estradiol, the most potent of these 3 estrogens. It mediates the growth and
function of the maternal reproductive organs and
probably is important to fetal growth and development. The reason for the large mass of estriol production is not clear. There is little evidence at the
moment that it is involved in the start of human
labor.
A biochemical effect of estrogen in pregnancy
or when given to a woman exogenously is the increased liver synthesis of certain steroid hormone
binding globulins. The increased hormone binding
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Fig. 3- Synthesis of estrogens by the human placenta. The pathways for the conversion of C19 steroids to estrogens are shown.
The major estrogens secreted by the placenta are boxed in. (Reprinted with permission from Villee. New Eng. J. Med. 281: 473, 1969.)

results in elevated concentrations of serum thyroxine (also the PBI), plasma cortisol, and testosterone. However, the amount of free or unbound
hormone, and presumably the biologically active
fraction, is unchanged. Unless this estrogen effect
is taken into account, the clinician can be misled
by the elevated laboratory result. The only exception to this physiologic change is for plasma cortisol
in pregnancy. The large amount of placental progesterone in pregnancy plasma competes with cortisol for binding sites on transcortin and increases
the free cortisol fraction. Therefore the pregnant
woman is actually in a state of mild adrenal hypercorticism.

C. Human Placental Lactogen (HPL). This
polypeptide hormone secreted by the syncitial
trophoblast is immunologically similar to but distinct
from human growth hormone. Metabolically it appears to be a weaker growth hormone. Its pattern
of secretion into the blood is shown in Fig. 8; the
increasing concentration throughout pregnancy
parallels the curve for placental weight. Like progesterone, its blood concentration reflects placental
rather than fetal integrity. Fetal death may not
significantly drop the level for a period of time as
long as the materno-placental circulation is intact.
The placental secretion is essentially unidirectional
into the mother; much lower levels being found in
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Fig. 4- Mean plasma levels of progesterone, 17-hydroxyprogesterone, and HCG following induction of ovulation with HMG-HCG
and subsequent conception. (Reprinted with permission from Yoshimi, et al. J. Clin. Endocr. 29: 225, 1969.)

the fetus. The daily production can be as high as
400 mgms.
Possible roles of HPL are preparation of the
breasts for successful lactation and indirect growth
hormone effects. These include increased nitrogen
retention, increased maternal fatty acid utilization
sparing glucose for transmission to the fetus. The
fetus, like the adult brain, utilizes essentially glucose
only for its energy requirements. HPL is antagonistic
to insulin and as a consequence may be an important

factor in the diabetogenic effect of pregnancy.
D. Human Chorionic Gonadotrophin (HCG).
The blood and urine levels of this glycoprotein
secreted by the cytotrophoblast differ from the
curves seen for the previousiy discussed horomones
;md is shown in Fig. 9. The concentration in the
blood peaks at about 60 days, then decreases to
% to V:3 of the peak value throughout pregnancy
with a lower secondary rise at term.
Its role in pregnancy is not clear, but tradition-

YAN NONE: HORMONAL CHANGES IN PREGNANCY

48
0

~ 26
~

•
•

Single Pregnancy (Spot Assays)
Twins
Single Pregnancy (Serial Assays)

~ 22

~

......
E:

0

•

18

vOo ••

0

0

§

~

~

14

<::s

10

"~
~
~
~
~
((

....::

~

6
2

24
30
36
12
18
6
42
WEEKS AFTER THE LAST MENSTRUAL PERIOd :

Fig. 5-The plasma progesterone concentration in normal pregnancy expressed as micrograms 3. One hundred and t1:Velve of these
179 determinations were reported previously. Note the progressive increase in concentration with advancing gestation. (Reprinted
with permission from Yannone. Steroids 13: 773, 1969.)

ally is believed to maintain the corpus luteum of
pregnancy. It may also regulate steroid secretion
by other glands; its possible ACTH effect on the
fetal adrenal cortex in early pregnancy has already
been mentioned.
Clinical Implications.
A. Progesterone and Pregnancy Status. Plasma
progesterone and urinary pregnanediol have been
measured in a variety of obstetric disorders to prognosticate dysfunction or to establish its presence.
Such diagnostic attempts have been less than satisfactory. Probably the primary reason for this is that
the hormone concentration can remain in the normal range even with fetal death as long as the uteroplacental circulation is intact. Other problems are
the wide day to day variation in the same individual
and the overlap of values in normal and abnormal
gestation. Even when the hormone concentration is
definitely subnormal, it is usually the effect of an
uncorrectable dysfunction rather than the cause.
Therefore exogenous progesterone substitution is
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Fig. 7- Urinary excretion of estriol-16-glucuronide during pregnancy in 31 normal women. The upper and lower dashed lines are
953 'confidence limits. (Reprinted with permission from Fuchs and Klopper (eds.). Endocrinology of Pregnancy, First Edition.
New York: Harper and Row , 1971.)

generally of little value. Similar problems are encountered when serial assays for HPL are used
as a diagnostic tool.
B. Progesterone and Adequacy of the Corpus
Luteum; Abortion. Of probable clinical value are the
use of serial plasma progesterone or urinary pregnanediol assays to evaluate corpus luteum adequacy in certain types of infertility and possibly a
few cases of first trimester abortion. Although the
majority of such abortions are due to uncorrectable
causes such as chromqsomal defects, a few could
be due to corpus luteum dysfunction with disharmonious transition of steroid hormone production to

the placenta. When such corpus luteum inadequacy
is incriminated, correction of the infertility or prevention of another abortion may be achieved by
insuring an adequate corpus luteum. However, not
by the use of exogenous progesterone replacement,
but rather by the judicious use of ovulatory inductors such as Clomid® or the gonadotrophins to
insure normal follicular maturation which will result
in a normal corpus luteum.
C. Progesterone-Term and Premature Labor.
Elucidation of the mechanism which institutes labor
wou~d enhance our capability to induce labor for
medical or convenience reasons and to stop pre-
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mature labor. The theory most often advanced to
explain the mechanism which institutes parturition
is the progesterone-block concept. This maintains
that progesterone suppresses myometrial contractility
during gestation and labor begins upon withdrawal
of the hormone. However, our studies and those of
others have not shown a significant and consistent
drop in circulating progesterone prior to labor's
onset. These findings do not exclude a protective
role for progesterone as an effective decrease may
occur that is not apparent in the circulating levels.
One possibility that we investigated was that the
concentration of free and active progesterone decreased with advancing pregnancy because of increased protein binding of the hormone. However,
we found the percentage of binding to remain
constant throughout pregnancy, which meant that
as the total progesterone concentration rose so did
the concentration in the bound and unbound fractions. With this negative finding we have turned to
studies which may show decreased progesterone
levels within the myometrial cells. Our results are
·
too preliminary to draw conclusions.
In spite of our ignorance as to how labor starts,
we are not totally devoid of therapeutic agents. Within
reason labor can be induced at term with oxytocin.
It is much less effective earlier in pregnancy. Prostaglandins such as F2a appear to be effective at term
as well as earlier in gestation. However, on parenteral
use in the first 2 trimesters, the therapeutic-toxic
difference becomes too narrow. This problem may
be overcome by using the prostaglandin locally in
the vagina to induce an indicated abortion or
premature labor. Lastly, with judicious use of
intravenous alcohol in premature labor, the expulsion of the fetus can be delayed a few days to a
few months in about 65 % of the patients.
D. Estriol and Complicated Pregnancies. The
most important clinical consideration at the moment
is the value of serial estriol determinations in the
management of high-risk pregnancies. While it can
be helpful in certain complications of pregnancy such
as diabetes mellitus, toxemia, and dysmaturity to
evaluate the fetal status, it is not without pitfalls.
First the clinician is at the mercy of the quality
control of the laboratory doing his assays. Inaccurate
results can lead to false security or ill-timed termination of pregnancy. Even with a good laboratory,
the results may not always reflect the true status of
the pregnancy. Unfortunately, our knowledge of
estrogen metabolism in pregnancy is inadequate to
explain such discrepancies any better than it can
explain why Rh isO:.immunized jeopardized preg-
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nancies do not show subnormal estriol levels. Even
more disconcerting is the fact that excellent clinicians
using good laboratories are reporting perinatal
losses in diabetic pregnancies no better or even
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Fig. 8-Human placental lactogen (HPL) in serum. The
80 black dots represent individual values, the open circles
represent the means for 4 week' intervals and the vertical
lines the standard error of the mean. The dash lines show
the upper and lower limits of all determinations in the controls. (Reprinted with permission from Sam ~an, et al. Am.
! . Obstet. Gynec. 104 :781, 1969. )
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worse than reputable clinics have reported prior to
the availability of this assay. So far there has not
been any conclusive evidence that a marked
reduction in fetal mortality has been obtained because of estriol determination. In this light, the
overzealous utilization of estriol assays as a substitute for rather than an adjunct to clinical management is foolhardy .
As an adjunct to clinical judgment, the literature
seems to agree on certain helpful points. These
are as follows:
1. Significant day to day variation requires
serial assays to determine a mean for each
patient.
2. In a suspect pregnancy, weekly or biweekly
assays should be done from about the 30th
week up to the time of reasonable maturity
(about 34th week) at which time daily or
every other day determinations should be
carried out.
3. In any complicated pregnancy which is 34
weeks or beyond, any precipitous fall from
normal levels of urinary estriol and which
is verified over 2 or more consecutive days
dictates immediate delivery.
4. Chronic low estriol levels in preeclamptic
toxemia or dysmaturity do not necessitate
interruption unless there is a precipitous
drop from the low mean. Such babies left
in utero may not grow very much, but they
do achieve greater maturity.
5. Urinary estriol levels can be expected to
be low in mothers with anencephalic mon-
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sters or on glucocorticoid therapy for medical reasons.
The development of new specific and sensitive
hormone assay methods and the increase in sophistication of metabolic studies has given us an impressive array of biochemical information concerning
the physiology and endocrinology of pregnancy.
However, the application of this knowledge to
the improvement of obstetrical care has been
difficult. This should not discourage us as medical
science must like the infant learn to crawl before
it can walk. Eventually we shall have all the facts
needed to obtain the obstetrical results that we
all desire. We have had a promising start.
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